Listing ceremony: Emcure Pharma IPO debuts with 31% premium on National Stock Exchange
During the subscription phase, the issue receives massive response from qualified institutions with the subscription of nearly 200 times NE ...
During the subscription phase, the issue receives massive response from qualified institutions with the subscription of nearly 200 times NE ...
The issue has been subscribed 1.22 times in the retail category and 1.92 times in the NII portion, on June ...
Price Band fixed at ₹960 per equity share of face value of ₹10 each to ₹1008 per equity share of ...
Studies have shown that 1 in 4 adults in India suffer from hypertension and 101 million people in India which ...
Baisakhi, a day of immense significance for Sikhs worldwide, is the perfect backdrop to celebrate their heritage, which includes selflessly ...
Already successful in the Indian market, Finerenone was first launched by Bayer in India in August 2022 under the brand ...
Cadila Pharmaceuticals has participated in nine mega healthcare initiatives of the district health department in Mehsana and supported authorities by ...
Sets new standards for ethical practices in corporate world Employees take the Integrity Pledge, reinforcing the company's dedication to ethical ...
Desidustat, a Zydus innovation, is first-of-its-kind oral treatment in India for anemia associated with Chronic Kidney Disease The drug will ...
Associated Chambers of Commerce and Industry of India (ASSOCHAM) hosts 2nd Healthcare Summit and Awards ceremony in New Delhi NE ...
Email:
ne.gowri1964@gmail.com
Phone:
9643255068
© 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com